Home About Us Research & Development Investors & Media Careers Contact Us

News Highlights

November 12, 2014
Concert Pharmaceuticals Reports Third Quarter 2014 Financial Results and Provides Update on CTP-354 Program; Conference Call Scheduled Today at 8:30 a.m. EST

November 11, 2014
Concert Pharmaceuticals to Present at Stifel 2014 Healthcare Conference on November 18, 2014

November 5, 2014

Concert Pharmaceuticals to Report Third Quarter 2014 Results on November 12, 2014



Welcome to Concert

Concert Pharmaceuticals is a clinical stage biopharmaceutical company. We apply our extensive knowledge of deuterium chemistry to discover and develop novel small molecule drugs.

In the News

Mass High Tech BioFlash: Concert -Good news for two of its partnered drugs
September 22, 2104

MedChem News
Deuterium Medicinal Chemistry: A New Approach to Drug Discovery and Development Read more

Issued U.S. Patents

Concert is building a broad patent estate. View List


Concert has presented at a number scientific meetings. View Poster presentations

  ©2009 Concert Pharmaceuticals, Inc.
Design by Digizyme
Home     Sitemap